AIIML was dealing in supplies worth Rs 7 to Rs 8 crore with the MCD annually. The MCD transferred five of its employees who were found to be involved in the fraud.
To prevent a repeat of AIIML experience the MCD has now introduced a new purchase policy to improve dealings with suppliers.
Manoj Parida, MCD’s additional commissioner (health) revealed that there were complaints about AIIML which had been supplying the MCD ayurvedic medicines for about seven to eight years. An inquiry by the CBI also found the company guilty.
To ensure that there is transparency, a policy of open tenders will be adopted in the future. “It has been found that for the last four to five years no tenders were floated to select companies to supply the ayurvedic drugs.
The same companies were getting the orders year after year. Now this will not happen,” Parida asserted.
Incidentally, the BJP alleged irregularities in the purchase of Ayurvedic medicines citing the budgetry allocations for the current financial year at a special standing committee meeting on Thursday.
The meeting was called to discuss the budget estimates for 2006-07 which were presented by MCD commissioner A K Nigam.
BJP leader Vijender Gupta disclosed that Rs 32 crore had been earmarked for ayurvedic medicines as compared to Rs 16 crore for allopathic medicines in 2005-06.